ME02448B - Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta - Google Patents
Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog traktaInfo
- Publication number
- ME02448B ME02448B MEP-2016-111A MEP11116A ME02448B ME 02448 B ME02448 B ME 02448B ME P11116 A MEP11116 A ME P11116A ME 02448 B ME02448 B ME 02448B
- Authority
- ME
- Montenegro
- Prior art keywords
- composition
- use according
- treatment
- infections
- respiratory tract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Claims (16)
1. lzolovani bakterijski soj koji pripada vrsti S. salivarius, deponovan u Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Njemačka, sa pristupnim brojem DSM 23307.
2. Bakterijski soj prema zahtjevu 1 za upotrebu u liječenju infekcija i/ili zapaljenja gornjeg respiratornog trakta.
3. Bakterijski soj prema zahtjevu 1 za upotrebu u liječenju infekcija gornjeg respiratornog trakta, poželjno za liječenje infekcija koje uzrokuju bolesti kao što su akutna upala srednjeg uha, recidiv upale srednjeg uha, upale sinusa, nazalne polipoze.
4. Bakterijski soj prema zahtjevu 1, naznačen time što su bakterije u suspenziji, osušene zamrzavanjem ili inaktivirane, pod uslovom da nisu ubljene.
5. Kompozicija koja sadrži bakterijski soj prema zahtjevu 1 za upotrebu u liječenju infekcija i/ili zapaljenja gornjeg respiratornog trakta.
6. Kompozicija koja sadrži bakterijski soj prema zahtjevu 1 za upotrebu u liječenju infekcija gornjeg respiratornog trakta, poželjno za liječenje infekcija koje uzrokuju bolesti kao sto su akutna upala srednjeg uha, recidiv upale srednjeg uha, upale sinusa, nazalne polipoze.
7. Kompozicija za upotrebu prema zahtjevu 5 ili 6 implementirana sušenjem zamrzavanjem bakterijskih kultura, miješanjem sušenjem zamrzavanjem bakterija, bilo u suspenziji sa vodom ili sa dalje pogodnim ekscipijensima i, opciono uz dodavanje dalje aktivnih sastojaka.
8. Kompozicija za upotrebu prema bilo kom zahtjevu od 5 do 7, naznačena time što је količina bakterija poželjno u opsegu između 103 i 1010 CFU, za svaki gram kompozicije.
9. Kompozicija za upotrebu prema bilo kom zahtjevu od 5 do 8, koja sadrži jednu ili vise farmaceutski prihvatljivih ekscipijenasa, aromatizirajućih agenasa ili nosača.
10. Kompozicja za upotrebu prema zahtjevu 9, naznačena time što su koгišćeni ekscipijensi: guma, ksantan guma, karboksimetil celuloza, sllikon, vazelin, beli meki parafin, magnezjjum stearat, maltodekstrin, manitol, skrob, glukoza, gliceгin, propilen glikol i ekvivalentni molekuli.
11. Kompozicija za upotrebu prema zahtjevu 9, naznačena time što su korišćeni nosači pogodni za poboljšanje bioraspoloživosti, stabllnosti i izdržljivosti mikгoorganizama.
12. Kompozicija za upotrebu prema zahtjevu 9, naznačena time što koгišćeni nosači poboljšavaju adheziju mikгoorganizama na povгšini sluzokoze, kao što је Bis-metoksi PEG-1З PEG-4З8/PPG-110 SMDI kopolimer.
13. Kompozicija za upotrebu prema bilo kom zahtjevu od 5 do 8 koja sadrzi antiinflamatorne agense kao što је 18-beta gliceгitinska kiselina.
14. Kompozicija za upotrebu prema bilo kom zahtjevu od 5 do 1З, naznačena time što је u bilo kom obliku pogodnom da se огdiniга topikalno, oralno ili putem respiratornog trakta.
15. Kompozicija za upotrebu prema zahtjevu 14, naznačena time što је u farmaceutskom obliku krema, losiona, geleva, masti, rastvora, suspenzija emulzija, kapsula, tableta, praškova, granula, sprejeva, kapi.
16. Kompozicija za upotrebu prema zahtjevu 15, naznačena time što је formulisana da se oгdinira putem respiratornog trakta od strane nebulizatora, sa ili bez propelenata.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM20100163 | 2010-04-07 | ||
| EP11721384.3A EP2555785B8 (en) | 2010-04-07 | 2011-04-07 | Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract |
| PCT/IT2011/000104 WO2011125086A1 (en) | 2010-04-07 | 2011-04-07 | Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02448B true ME02448B (me) | 2016-09-20 |
Family
ID=42795606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2016-111A ME02448B (me) | 2010-04-07 | 2011-04-07 | Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20130095044A1 (me) |
| EP (1) | EP2555785B8 (me) |
| BR (1) | BR112012025640A2 (me) |
| CA (1) | CA2800514C (me) |
| CY (1) | CY1117633T1 (me) |
| DK (1) | DK2555785T3 (me) |
| ES (1) | ES2573729T3 (me) |
| HR (1) | HRP20160580T1 (me) |
| HU (1) | HUE030227T2 (me) |
| IL (1) | IL222333A (me) |
| ME (1) | ME02448B (me) |
| MX (1) | MX342226B (me) |
| PL (1) | PL2555785T3 (me) |
| PT (1) | PT2555785E (me) |
| RS (1) | RS54837B1 (me) |
| SI (1) | SI2555785T1 (me) |
| SM (2) | SMP201200048B (me) |
| WO (1) | WO2011125086A1 (me) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10626294B2 (en) | 2012-10-15 | 2020-04-21 | L'oreal | Aqueous wax dispersions containing volatile solvents |
| US9408785B2 (en) | 2012-10-15 | 2016-08-09 | L'oreal | Hair styling compositions containing aqueous wax dispersions |
| US10413496B2 (en) | 2012-10-15 | 2019-09-17 | L'oreal | Aqueous wax dispersions |
| US10561596B2 (en) | 2014-04-11 | 2020-02-18 | L'oreal | Compositions and dispersions containing particles comprising a polymer |
| EP3015110A1 (en) | 2014-10-28 | 2016-05-04 | D.M.G. Italia Srl | Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections |
| EP3015109B1 (en) | 2014-10-28 | 2019-09-18 | D.M.G. Italia Srl | Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections |
| AU2021248774B2 (en) * | 2020-04-03 | 2025-06-05 | Blis Technologies Limited | Antiviral treatment comprising blis containing probiotic products |
| US20230407241A1 (en) * | 2020-09-04 | 2023-12-21 | Universiteit Antwerpen | A novel probiotic streptococcus salivarius strain and its uses |
| ES2973007A1 (es) * | 2024-01-11 | 2024-06-17 | Darwin Bioprospecting Excellence S L | Probiotico oral |
| CN120098866B (zh) * | 2025-05-09 | 2025-10-28 | 天津芯源生物科技有限公司 | 唾液链球菌嗜热亚种dy-001及其细菌素、冻干粉在治疗上呼吸道感染中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776462A (en) * | 1996-12-10 | 1998-07-07 | Sage R&D, A Partnership | Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat |
| BR0014740A (pt) | 1999-10-12 | 2002-06-18 | Blis Technologies Ltd | Lantibiótico |
| TW200400262A (en) * | 2002-02-22 | 2004-01-01 | Blis Technologies Ltd | Antimicrobial composition |
| WO2004072272A1 (en) | 2003-02-14 | 2004-08-26 | Blis Technologies Limited | Bacterial compositions |
-
2011
- 2011-04-07 ME MEP-2016-111A patent/ME02448B/me unknown
- 2011-04-07 BR BR112012025640A patent/BR112012025640A2/pt not_active Application Discontinuation
- 2011-04-07 WO PCT/IT2011/000104 patent/WO2011125086A1/en not_active Ceased
- 2011-04-07 SI SI201130865A patent/SI2555785T1/sl unknown
- 2011-04-07 HU HUE11721384A patent/HUE030227T2/en unknown
- 2011-04-07 HR HRP20160580TT patent/HRP20160580T1/hr unknown
- 2011-04-07 PT PT117213843T patent/PT2555785E/pt unknown
- 2011-04-07 PL PL11721384.3T patent/PL2555785T3/pl unknown
- 2011-04-07 DK DK11721384.3T patent/DK2555785T3/en active
- 2011-04-07 EP EP11721384.3A patent/EP2555785B8/en active Active
- 2011-04-07 ES ES11721384.3T patent/ES2573729T3/es active Active
- 2011-04-07 CA CA2800514A patent/CA2800514C/en active Active
- 2011-04-07 MX MX2012011706A patent/MX342226B/es active IP Right Grant
- 2011-04-07 RS RS20160421A patent/RS54837B1/sr unknown
-
2012
- 2012-10-04 US US13/644,357 patent/US20130095044A1/en not_active Abandoned
- 2012-10-09 IL IL222333A patent/IL222333A/en active IP Right Grant
- 2012-11-06 SM SM201200048T patent/SMP201200048B/xx unknown
-
2016
- 2016-06-14 CY CY20161100519T patent/CY1117633T1/el unknown
- 2016-06-20 SM SM201600190T patent/SMT201600190B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL222333A0 (en) | 2012-12-31 |
| BR112012025640A2 (pt) | 2016-06-28 |
| PT2555785E (pt) | 2016-06-08 |
| RS54837B1 (sr) | 2016-10-31 |
| DK2555785T3 (en) | 2016-06-13 |
| ES2573729T3 (es) | 2016-06-09 |
| US20130095044A1 (en) | 2013-04-18 |
| PL2555785T3 (pl) | 2016-12-30 |
| SMT201600190B (it) | 2016-08-31 |
| SI2555785T1 (sl) | 2016-07-29 |
| IL222333A (en) | 2017-02-28 |
| CY1117633T1 (el) | 2017-04-26 |
| SMAP201000048A (it) | 2013-01-14 |
| WO2011125086A1 (en) | 2011-10-13 |
| EP2555785B8 (en) | 2016-07-13 |
| HUE030227T2 (en) | 2017-05-29 |
| EP2555785A1 (en) | 2013-02-13 |
| MX2012011706A (es) | 2013-03-08 |
| CA2800514C (en) | 2019-06-18 |
| CA2800514A1 (en) | 2011-10-13 |
| SMP201200048B (it) | 2013-07-09 |
| EP2555785B1 (en) | 2016-04-06 |
| MX342226B (es) | 2016-09-21 |
| HRP20160580T1 (hr) | 2016-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02448B (me) | Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta | |
| US10449222B2 (en) | Method for preventing and/or treating infections, colonisations, or illnesses related to Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur | |
| CA3132858A1 (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | |
| TW201703654A (zh) | 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物 | |
| CN112402459B (zh) | 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用 | |
| RU2011124506A (ru) | Фармацевтический препарат, содержащий комбинацию штаммов streptococcus и штаммов lactobacillus | |
| RU2010142003A (ru) | Синбиотическая смесь | |
| JP2010053062A (ja) | 口腔用組成物 | |
| CN115607577A (zh) | 一种具有缓解口腔炎症功效的益生菌剂及其制备方法和应用 | |
| US20110039765A1 (en) | Bioactive Molecules Produced by Probiotic Bacteria | |
| CN107405370A (zh) | 含有Lactococcus chungangensis作为有效成分的用于预防或治疗炎性疾病的药物组合物 | |
| CN108611295B (zh) | 一种缓解内毒素感染的脆弱拟杆菌及其应用 | |
| TW202233826A (zh) | 新型乳桿菌屬菌株及其用途 | |
| WO2012103785A1 (zh) | 唾液乳杆菌及其代谢物的制备方法和组合物以及应用 | |
| CN115927122A (zh) | 副干酪乳酪杆菌制备的具有促进宿主ha合成并增强ha应用效果的后生元 | |
| CN111320678B (zh) | 抗菌肽突变体及其应用 | |
| JP2001158743A (ja) | 乳酸菌含有組成物、医薬及び食品 | |
| TWI496578B (zh) | 流感病毒感染症的治療劑 | |
| EP3015109B1 (en) | Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections | |
| WO2023108080A1 (en) | Bacillus coagulans strain, compositions thereof, and methods of use | |
| CN114908023A (zh) | 一株提高肠道放线菌门相对丰度、抑制促炎症因子表达量的凝结芽孢杆菌 | |
| WO2018122762A1 (en) | Oral preparation comprising a probiotic preparation of lactobacilluls helveticus | |
| KR102439760B1 (ko) | 상기도 감염균 질환 예방 및 치료를 위한 조성물 | |
| KR102401971B1 (ko) | 박하 추출물을 함유하는 바이오필름 형성 억제용 조성물 | |
| KR20240086453A (ko) | 바실러스 서브틸리스 균주를 포함하는 항염증용 조성물 |